| Efficacy of COVID-19 treatments: a Bayesian network meta-analysis of randomized controlled trials C Zhang, H Jin, YF Wen, G Yin Frontiers in Public Health 9, 729559, 2021 | 45 | 2021 |
| Restricted mean survival time for interval‐censored data C Zhang, Y Wu, G Yin Statistics in Medicine 39 (26), 3879-3895, 2020 | 10 | 2020 |
| Prevention of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines. M Santacatterina, JW Sanders, WS Weintraub | 8 | 2021 |
| Statistical issues and lessons learned from COVID-19 clinical trials with lopinavir-ritonavir and remdesivir G Yin, C Zhang, H Jin JMIR Public Health and Surveillance 6 (3), e19538, 2020 | 6 | 2020 |
| Biostatistics pitfalls: Lessons learned from analysis of medical data G Yin, C Zhang, Z Yang Contemporary Clinical Trials 87, 105875, 2019 | 3 | 2019 |
| Bayesian nonparametric analysis of restricted mean survival time C Zhang, G Yin Biometrics 79 (2), 1383-1396, 2023 | 1 | 2023 |
| Safety of paclitaxel-coated devices in the femoropopliteal arteries: A systematic review and meta-analysis C Zhang, G Yin PLoS One 17 (10), e0275888, 2022 | 1 | 2022 |
| Reduction in number to treat versus number needed to treat C Zhang, G Yin BMC Medical Research Methodology 21, 1-10, 2021 | 1 | 2021 |
| Reanalysis of Data Comparing Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non–Small Cell Lung Cancer—In Reply A Sun, C Hu JAMA oncology 5 (11), 1638-1639, 2019 | | 2019 |
| Fast and Stable Maximum Likelihood Estimation for Incomplete Multinomial Models C Zhang, G Yin International Conference on Machine Learning, 7463-7471, 2019 | | 2019 |
